Previous close | 6.82 |
Open | 6.82 |
Bid | 6.49 x 500 |
Ask | 6.55 x 400 |
Day's range | 6.48 - 6.88 |
52-week range | 1.28 - 16.24 |
Volume | |
Avg. volume | 1,029,296 |
Market cap | 460.153M |
Beta (5Y monthly) | 0.89 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Insights into Nkarta's Financial Health and Strategic Developments in Cell Therapy
Nkarta stock surged Monday — partially reversing a 31% dive on Friday — after unveiling promising test results for its lymphoma treatment.